Medullary thyroid cancer historical perspective

Jump to: navigation, search

Medullary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medullary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Medullary thyroid cancer historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Medullary thyroid cancer historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Medullary thyroid cancer historical perspective

CDC on Medullary thyroid cancer historical perspective

Medullary thyroid cancer historical perspective in the news

Blogs on Medullary thyroid cancer historical perspective

Directions to Hospitals Treating Medullary thyroid cancer

Risk calculators and risk factors for Medullary thyroid cancer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Medullary thyroid cancer was first discovered by Dr. John Beach Hazard, an American pathologist, in 1959.

Historical Perspective

  • In 1959, Dr. Hazard described medullary (solid) thyroid carcinoma.[1][2]
  • In 1961, Dr. Sipple described a combination of a pheochromocytoma, medullary thyroid carcinoma, and parathyroid adenoma.
  • In 1966, Dr. Williams proposed the C-cells as the origin of medullary thyroid cancer.[3]
  • In 1966, Dr. Pearse proposed the name C-cell indicating their function in calcitonin secrestion.[4]
  • In 1978, Dr. Cameron suggested that medullary thyroid cancer produces thyrocalcitonin from parafollicular cells.

References

  1. HAZARD JB, HAWK WA, CRILE G (1959). "Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity". J. Clin. Endocrinol. Metab. 19 (1): 152–61. doi:10.1210/jcem-19-1-152. PMID 13620740.
  2. Dionigi G, Bianchi V, Rovera F, et al. (2007). "Medullary thyroid carcinoma: surgical treatment advances". Expert Rev Anticancer Ther. 7 (6): 877–85. doi:10.1586/14737140.7.6.877. PMID 17555398.
  3. Williams, E. D. (1966). "Histogenesis of medullary carcinoma of the thyroid". Journal of Clinical Pathology. 19 (2): 114–118. doi:10.1136/jcp.19.2.114. ISSN 0021-9746.
  4. "The cytochemistry of the thyroid C cells and their relationship to calcitonin". Proceedings of the Royal Society of London. Series B. Biological Sciences. 164 (996): 478–487. 1966. doi:10.1098/rspb.1966.0044. ISSN 2053-9193.

Linked-in.jpg